Skip to main content
Diseases

Substance Withdrawal Syndrome

substance withdrawal syndrome

Entity Type
Diseases
Relation Groups
1
Relation Preview
8

Basic Information

Grouped by core information, identifiers, and descriptions.

Quick relations do not expand inferred candidates by default. Load path-derived ingredients or herbs when needed.

Core Information

Disease Name
Substance Withdrawal Syndrome
Standard Disease Name
substance withdrawal syndrome
MeSH Tree
No data
ICD-10
No data

Identifiers

DO ID
No data
MeSH ID
D013375
OMIM ID
No data
UMLS ID
C0038587
HPO ID
No data

Description and Extensions

Description
NCI2016_02D:A substance-specific organic brain syndrome that follows the discontinuation of administration or use, or reduction in intake of an addictive substance, e.g. opioids, barbiturates and alcohol; amphetamines or similarly acting sympathomimetics; cocaine; nicotine; sedatives, hypnotics, or anxiolytics. Syndrome manifests with diverse, often painful physical and psychological symptoms, which include but not limited to intense drug craving, anxiety, depression, insomnia, nausea, perspiration, body aches, tremors, hallucinations, and convulsions.|MSH2017_2016_08_12:Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.
Related

Direct relations and traceable candidates grouped by relation type.

Related Targets

target disease8 Targets
04
GRIA2
glutamate ionotropic receptor AMPA type subunit 2
glutamate ionotropic receptor AMPA type subunit 2
07
RUNX2
RUNX family transcription factor 2
RUNX family transcription factor 2